213 related articles for article (PubMed ID: 7591618)
1. [Beta 2-sympathomimetic drugs].
Criée CP; Laier-Groeneveld G
Internist (Berl); 1995 Sep; 36(9):918-23. PubMed ID: 7591618
[No Abstract] [Full Text] [Related]
2. Salmeterol.
Med Lett Drugs Ther; 1994 Apr; 36(921):37-9. PubMed ID: 7909139
[No Abstract] [Full Text] [Related]
3. Inhaled beta 2-agonists and corticosteroids in the treatment of children with acute asthma attack.
Volovitz B; Nussinovitch M
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):891-2. PubMed ID: 12455174
[No Abstract] [Full Text] [Related]
4. [beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study].
Riedl-Seifert R
Dtsch Med Wochenschr; 2007 Mar; 132(12):633; author reply 633-4. PubMed ID: 17357910
[No Abstract] [Full Text] [Related]
5. [The therapeutic potentials of Berotec-100 in bronchial asthma patients].
Emel'ianov AV; Shevelev SE; Shubin SA; Sinitsina TM; Fedoseev GB
Klin Med (Mosk); 1998; 76(7):38-9. PubMed ID: 9742777
[No Abstract] [Full Text] [Related]
6. Long acting beta2 agonists: are they safe?
Wijesiriwardena B
Ceylon Med J; 2006 Dec; 51(4):129-31. PubMed ID: 17461321
[No Abstract] [Full Text] [Related]
7. Beta-adrenergic bronchodilators.
Nelson HS
N Engl J Med; 1995 Aug; 333(8):499-506. PubMed ID: 7623883
[No Abstract] [Full Text] [Related]
8. Asthma and the beta 2-agonist controversy: much ado about something.
Lieberman JS; Kane GC
Del Med J; 1995 Dec; 67(12):624-8. PubMed ID: 8557164
[No Abstract] [Full Text] [Related]
9. beta-adrenergic receptor genotype and response to salmeterol.
Wechsler ME; Israel E
J Allergy Clin Immunol; 2007 Jul; 120(1):218-9; author reply 219-20. PubMed ID: 17399776
[No Abstract] [Full Text] [Related]
10. Filling in the gaps.
Roberts J
Nurs Stand; 2002 May 15-21; 16(35):27. PubMed ID: 12212333
[No Abstract] [Full Text] [Related]
11. Salmeterol response and beta(2)-adrenergic receptor genotype.
Jackson C; Lipworth B
J Allergy Clin Immunol; 2007 Jul; 120(1):217-8; author reply 219-20. PubMed ID: 17399780
[No Abstract] [Full Text] [Related]
12. Risks of long-acting beta-agonists in achieving asthma control.
Drazen JM; O'Byrne PM
N Engl J Med; 2009 Apr; 360(16):1671-2. PubMed ID: 19369675
[No Abstract] [Full Text] [Related]
13. beta-Adrenergic bronchodilators and sudden death in asthmatics.
Drug Ther Bull; 1976 Mar; 14(6):21-2. PubMed ID: 6237
[No Abstract] [Full Text] [Related]
14. Beta 2-agonist bronchodilators--advances versus controversies.
O'Donnell SR
Proc West Pharmacol Soc; 1993; 36():323-7. PubMed ID: 8104346
[No Abstract] [Full Text] [Related]
15. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
17. Continuous eformoterol and beta 2-receptor responsiveness.
Sussman HS
Br J Clin Pract Suppl; 1995 Sep; 81():16-7. PubMed ID: 8546889
[No Abstract] [Full Text] [Related]
18. Bronchodilator therapy in the management of acute asthma.
Moan MJ; Fanta CH
Compr Ther; 1995 Aug; 21(8):421-7. PubMed ID: 8536441
[TBL] [Abstract][Full Text] [Related]
19. Salmeterol and paroxetine: more evidence for paradoxical medicine.
Yun AJ; Lee PY; Doux JD
Med Hypotheses; 2006; 66(5):1037-8. PubMed ID: 16364562
[No Abstract] [Full Text] [Related]
20. Inhaled beta 2-adrenergic agonists in asthma: the evolving dilemma.
Hui KP
Singapore Med J; 1994 Jun; 35(3):237-9. PubMed ID: 7997893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
